A meta-analysis of randomized trials assessing the effects of probiotic preparations on oral candidiasis in the

Ruixue Ai1, Jiao Wei1, Danhua Ma1

  • 1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China.

Abstract

Insights

Probiotics can help prevent oral candidiasis, a common fungal infection, in elderly individuals. This systematic review found that probiotics significantly reduce the risk of this condition in older adults.

Area of Science:

  • Oral health
  • Microbiology
  • Gerontology

Background:

  • Oral candidiasis is a common fungal infection often linked to oral microflora imbalance (dysbiosis).
  • Probiotics are explored for their potential to counteract pathogenic microorganisms in the oral cavity.
  • The efficacy of probiotics in preventing oral candidiasis in the elderly remains debated.

Purpose of the Study:

  • To conduct a systematic review and critical appraisal of clinical trials on probiotics for preventing oral candidiasis in the elderly.
  • To synthesize evidence regarding the preventative effects of probiotics on oral candidiasis in geriatric populations.

Main Methods:

  • Systematic literature search of PubMed, Embase, and Cochrane databases.
  • Inclusion of only randomized controlled trials (RCTs).
  • Meta-analysis using the Mantel-Haenszel test to calculate pooled odds ratios.

Main Results:

  • Four RCTs involving 595 participants were analyzed.
  • The overall combined odds ratio for oral candidiasis was 0.54 (95% CI: 0.38-0.77), indicating a reduced risk with probiotic use.
  • Three studies showed a significant reduction in oral candidiasis risk with active probiotic treatment compared to placebo.

Conclusions:

  • Probiotics demonstrate a preventative effect against oral candidiasis in the elderly population.
  • The findings support the use of probiotics as a strategy to manage oral candidiasis in older adults.

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
267
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
278
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
761